Tasigna 50 MG Oral Capsule

RxCUI: 2002719
RxNorm name: Tasigna 50 MG Oral Capsule
Display name: Tasigna 50 MG Oral Capsule
Full name: Tasigna 50 MG Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tasigna	NILOTINIB	Novartis Pharmaceuticals Corporation	6093952a-5248-45cb-ad17-33716a411146	2025-12-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2002719

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6093952a-5248-45cb-ad17-33716a411146	Tasigna 50 MG Oral Capsule [PSN] · nilotinib 50 MG Oral Capsule [Tasigna] [SBD] · Tasigna 50 MG Oral Capsule [SY]	3	42	These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 2007	20251216